Trial Details

COMPLETED
Basic Information
Clinical ID c1437
Identifier NCT00033943
Trial Title Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: deligoparin
Participant Information
Sponsor Incara Pharmaceuticals
City Anaheim
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2025-01-01
Primary Completion Date -
Completion Date 2025-09-02